Literature DB >> 13515164

[Serotonin and intestinal motility].

H KAHR.   

Abstract

Entities:  

Keywords:  INTESTINES/physiology; SEROTONIN/effects

Mesh：

Substances：

Year:  1957        PMID： 13515164     DOI： 10.1007/bf01497710

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


× No keyword cloud information.
  23 in total

1.  Studies on tryptophan and serotonin in patients with malignant carcinoid.

Authors:  S UDENFRIEND; H WEISSBACH; A SJOERDSMA
Journal:  Science       Date:  1956-04-20       Impact factor: 47.728

2.  Further observations on the endocrine aspects of argentaffinoma.

Authors:  C E DALGLIESH; R W DUTTON; B LENNOX; P S MACFARLANE; L M NYLUS; A N SMITH
Journal:  Scott Med J       Date:  1957-01       Impact factor: 0.729

3.  5-Hydroxytryptamine antagonists, with special reference to the importance of sympathomimetic amines and isopropyl-noradrenaline.

Authors:  R JAQUES; H J BEIN; R MEIER
Journal:  Helv Physiol Pharmacol Acta       Date:  1956

4.  Endocrine aspects of argentaffinoma, with special reference to the use of urinary 5-hydroxyindoleacetic acid estimations in diagnosis.

Authors:  P S MACFARLANE; C E DALGLIESH; R W DUTTON; B LENNOX; L M NYHUS; A N SMITH
Journal:  Scott Med J       Date:  1956-04       Impact factor: 0.729

5.  Interaction of reserpine, serotonin, and lysergic acid diethylamide in brain.

Authors:  P A SHORE; S L SILVER; B B BRODIE
Journal:  Science       Date:  1955-08-12       Impact factor: 47.728

6.  Serotonin release as a possible mechanism of reserpine action.

Authors:  A PLETSCHER; P A SHORE; B B BRODIE
Journal:  Science       Date:  1955-08-26       Impact factor: 47.728

7.  [5-Hydroxytryptamine in carcinoids of the gastrointestinal system].

Authors:  M RATZENHOFER; F LEMBECK
Journal:  Z Krebsforsch       Date:  1954

8.  Malignant carcinoid of the small intestine with metastases to the liver, valvular disease of the right side of the heart (pulmonary stenosis and tricuspid regurgitation without septal defects), peripheral vasomotor symptoms, bronchoconstriction, and an unusual type of cyanosis; a clinical and pathologic syndrome.

Authors:  A THORSON; G BIORCK; G BJORKMAN; J WALDENSTROM
Journal:  Am Heart J       Date:  1954-06       Impact factor: 4.749

9.  Action of reserpine on the 5-hydroxytryptamine (enteramine) biosynthesis and metabolism in dogs and rats.

Authors:  V ERSPAMER; C CICERI
Journal:  Experientia       Date:  1957-02-15

10.  Effect of reserpine on 5-hydroxytryptamine (serotonin) in rabbit serum.

Authors:  K NAESS; S SCHANCHE
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1956
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.